Stay updated on Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial page.
Latest updates to the Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check41 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference1%
- Check56 days agoChange DetectedThe website has added a 'Show less' feature while removing extensive details about participant groups, interventions, and various data fields available for download.SummaryDifference2%
- Check70 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the 'Show less' option and the previous version v2.12.1.SummaryDifference2%
- Check78 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.0%
Stay in the know with updates to Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Palbociclib With Standard Treatment in Residual Breast Cancer Clinical Trial page.